2 ML omalizumab 150 MG/ML Prefilled Syringe [Xolair]

RxNorm concept 2663918, branded drug (sbd). Prescribable name: Xolair 300 MG in 2 ML Prefilled Syringe.

RxCUI: 2663918
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2663918 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

omalizumab 302379

Other names

Xolair 300 MG per 2 ML Prefilled Syringe

Related concepts

omalizumab 150 MG/ML (SCDC, consists of)
omalizumab 150 MG/ML [Xolair] (SBDC, consists of)
Prefilled Syringe (DF, has dose form)
Xolair (BN, has ingredient)
2 ML omalizumab 150 MG/ML Prefilled Syringe (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2663918 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2663918 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2663918. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.